For the Inventor, By the Inventor

Enter inventor name

Wallingford, CT, United States of America

Bernd Kaiser

USPTO Granted Patents = 5 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 12.4

ph-index = 4

Forward Citations = 63(Granted Patents)

Location History:

Walingford, CT (US) (2011)
Plainsboro, NJ (US) (2011)
Wallingford, CT (US) (2006 - 2020)

Company Filing History:

Schering Corporation

Pharmacopeia Drug Discovery, Inc.

4. 1 out of 305

Neurogen Corporation

where one patent can have more than one assignee

Years Active: 2006-2020

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10669296 - LXR agonists and uses thereof (2020-06-02),

2. 7964646 - 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands (2011-06-21),

3. 7947720 - 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands (2011-05-24),

4. 7179807 - 5-substituted-2-arylpyrazines (2007-02-20),

5. 7132445 - 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands (2006-11-07),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…